Skip to Main Content
Close
Who We Serve
Overview
Researchers
Authors
Reviewers
Healthcare Professionals
Patients & Their Supporters
Librarians
Health Sciences Industry
Societies
Agents & Distributors
What We Offer
Overview
Subject Areas
Journals
Books & Book Series
Collections
Courses
Podcasts
Open Access
What We Solve
Overview
Accessing Knowledge
Presenting Knowledge
Applying Knowledge
About Us
Publish with Us
Overview
Publish Your Paper
Calls for Papers
Open Access Publishing
Publication Services
Partner Publications
Publication Ethics
Resources for You
Overview
Experience Karger
The Waiting Room
Embarrassing Problems
Nephrology Viewpoints
ISCN Online
DermaCompass
Search Dropdown Menu
header search
search input
Search input auto suggest
filter your search
All Content
All Journals
Neuroimmunomodulation
Search
Advanced Search
User Tools Dropdown
Register
Login
Toggle Menu
Menu
Content
Articles
Issues
Early View
Viewpoints
About
Details
Contact
Editorial Board
Guidelines
Open Access
Rights & Permissions
Advertising
Submission
Skip Nav Destination
Issues
Select Year
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994
Issue
January - Volume 29, Issue 1, Pages 1 - 84
April - Volume 29, Issue 2, Pages 85 - 170
July - Volume 29, Issue 3, Pages 171 - 250
September - Volume 29, Issue Suppl. 2, Pages 1 - 34
March - Volume 29, Issue Suppl. 1, Pages 1 - 50
December - Volume 29, Issue 4, Pages 251 - 523
Volume 29, Issue Suppl. 1
March 2022
ISSN 1021-7401
EISSN 1423-0216
Close navigation menu
In this Issue
Abstracts
Issue Navigation
Search within issue:
Search within issue
Neuroimmunomodulation 2022, Vol. 29, Suppl. 1
Abstracts
All Issues
Email alerts
Online First Alert
Continuous Publishing Alert
New Content Alert
Close Modal
Latest
Most Read
Most Cited
Modulation of neuroinflammation: advances in roles and mechanisms of IL-33/ST2 axis involved in ischemic stroke
15th Conference of the German Endocrine-Brain- Immune-Network (GEBIN) Ulm, Germany, September 28 – September 30, 2023
:
GEBIN 2023
Erratum - GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease
Hypothalamic-pituitary axis function and adrenal insufficiency in COVID-19 patients
RSS
Current Issue RSS Feed
Open Issues RSS Feed
Close Modal
Close Modal
This Feature Is Available To Subscribers Only
Sign In
or
Create an Account
Close Modal
Close Modal